Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Epigenetics in cancer stem cells
Compelling evidence have demonstrated that bulk tumors can arise from a unique subset of
cells commonly termed “cancer stem cells” that has been proposed to be a strong driving …
cells commonly termed “cancer stem cells” that has been proposed to be a strong driving …
Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia
BJ Wouters, R Delwel - Blood, The Journal of the American …, 2016 - ashpublications.org
Acute myeloid leukemia (AML) is the most common type of acute leukemia in adults. AML is
a heterogeneous malignancy characterized by distinct genetic abnormalities. Recent …
a heterogeneous malignancy characterized by distinct genetic abnormalities. Recent …
A DNA hypomethylation signature predicts antitumor activity of LSD1 inhibitors in SCLC
HP Mohammad, KN Smitheman, CD Kamat, D Soong… - Cancer cell, 2015 - cell.com
Epigenetic dysregulation has emerged as an important mechanism in cancer. Alterations in
epigenetic machinery have become a major focus for targeted therapies. The current report …
epigenetic machinery have become a major focus for targeted therapies. The current report …
Targeting long non-coding RNAs in cancers: progress and prospects
CH Li, Y Chen - The international journal of biochemistry & cell biology, 2013 - Elsevier
Pervasive transcription occurs in the human genome to generate thousands of RNA
transcripts, and accumulating evidence suggested that the RNA molecules, without protein …
transcripts, and accumulating evidence suggested that the RNA molecules, without protein …
Chromatin proteins and modifications as drug targets
K Helin, D Dhanak - Nature, 2013 - nature.com
A plethora of groundbreaking studies have demonstrated the importance of chromatin-
associated proteins and post-translational modifications of histones, proteins and DNA (so …
associated proteins and post-translational modifications of histones, proteins and DNA (so …
Enhancer activation by pharmacologic displacement of LSD1 from GFI1 induces differentiation in acute myeloid leukemia
Pharmacologic inhibition of LSD1 promotes blast cell differentiation in acute myeloid
leukemia (AML) with MLL translocations. The assumption has been that differentiation is …
leukemia (AML) with MLL translocations. The assumption has been that differentiation is …
LSD1: biologic roles and therapeutic targeting
A Maiques-Diaz, TCP Somervaille - Epigenomics, 2016 - Taylor & Francis
LSD1 (KDM1A; BHC110; AOF2) was the first protein reported to exhibit histone demethylase
activity and has since been shown to have multiple essential roles in mammalian biology …
activity and has since been shown to have multiple essential roles in mammalian biology …
A systematic review of histone lysine‐specific demethylase 1 and its inhibitors
YC Zheng, J Ma, Z Wang, J Li, B Jiang… - Medicinal research …, 2015 - Wiley Online Library
Histone lysine‐specific demethylase 1 (LSD1) is the first discovered and reported histone
demethylase by Dr. Shi Yang's group in 2004. It is classified as a member of amine oxidase …
demethylase by Dr. Shi Yang's group in 2004. It is classified as a member of amine oxidase …
Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner
The long non-coding RNA Hox transcript antisense intergenic RNA (HOTAIR) was recently
implicated in breast cancer metastasis and is predictive of poor prognosis in colorectal and …
implicated in breast cancer metastasis and is predictive of poor prognosis in colorectal and …
[HTML][HTML] The histone LSD1 demethylase in stemness and cancer transcription programs
DNA and histone chromatin modifying enzymes play a crucial role in chromatin remodeling
in several biological processes. Lysine-specific demethylase 1 (LSD1), the first identified …
in several biological processes. Lysine-specific demethylase 1 (LSD1), the first identified …